Bernard Châtelain

Impact of dabigatran on a large panel of routine or specific coagulation assays

Séverine Robert, C Chatelain, Jonathan Douxfils et al. · Thrombosis and Haemostasis · 2012 · 322 citations

Medicine, Hematology, Pharmacology +17

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

C Chatelain, Bernard Châtelain, Jonathan Douxfils et al. · Thrombosis and Haemostasis · 2013 · 210 citations · Full text

Medicine, Hematology, Pharmacology +17

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Anne Tamigniau, Bernard Châtelain, C Chatelain et al. · Thrombosis and Haemostasis · 2013 · 150 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

Jean-Michel Dogné, François Mullier, Bernard Châtelain et al. · Thrombosis and Haemostasis · 2013 · 103 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Characterisation of tissue factor‐bearing extracellular vesicles with AFM: comparison of air‐tapping‐mode AFM and liquid Peak Force AFM

Julie Hardij, Francesca Cecchet, Alexandre Berquand et al. · Journal of Extracellular Vesicles · 2013 · 90 citations · Full text

Natural Sciences, Biophysics, Cell Biology +14